Pioneer of IVF Wins Nobel Prize; Anti-Choice Tantrums Ahead
Biologist Robert G. Edwards has won the Nobel Prize for his work on in vitro fertilization. Edwards and his late colleague, gynecologist Patrick Steptoe, helped an infertile woman give birth to the world's first "test tube baby" in July of 1978.
According to the New York Times, the initial controversy over IVF has pretty much died out:
Though in vitro fertilization is now widely accepted, the birth of the first test tube baby was greeted with intense concern that the moral order was subverted by unnatural intervention in the mysterious process of creating a human being. Dr. Edwards was well aware of the ethical issues raised by his research and took the lead in addressing them.
The objections gradually died away, except on the part of the Roman Catholic Church, as it became clear that the babies born by in vitro fertilization were healthy and that their parents were overjoyed to be able to start a family. Long-term follow-ups have confirmed the essential safety of the technique. [NYT]
The rest of the world is comfortable with IVF, as evidenced by today's Nobel Prize announcement. However, anti-choice extremists are still fighting that battle here in the United States.
It would be political suicide to challenge IVF directly. (Update: Anti-choicers in Colorado didn't get that memo.) For the most part, anti-choicers don't want to be seen denying infertile couples their only chance to have a biological family. Instead, they've chosen an more abstract target in the great battle between embryos and women: Embryonic stem cell research.
IVF treatments produce many more embryos than will ultimately become pregnancies. So, a lot of embryos are discarded or frozen indefinitely. Some are turned into embryonic stem cell lines.
All federally-funded research involving human embryonic stem cells ground to a court-ordered halt earlier this year while a federal judge weighed a lawsuit challenging this kind of funding. Research dollars are flowing again, thanks to a temporary reprieve from a higher court.
Ron Johnson, the GOP senate candidate in Wisconsin said last week that he opposes embryonic stem cell research. "If there's a program "that's morally objectionable to a high percentage of the American public, that's probably something we shouldn't spend money on," Johnson told the AP. Johnson's opponent, Sen. Russ Feingold, strongly supports the research.
[Photo credit: Shows the kind of HESC that were injected into the spine of a patient with ALS, a lethal motor neuron disease, via CNN Health.]
Swipe right to make the connections that could change your career.
Swipe right. Match. Meet over coffee or set up a call.
No, we aren't talking about Tinder. Introducing Shapr, a free app that helps people with synergistic professional goals and skill sets easily meet and collaborate.
The Oxfam report prompted Anand Giridharadas to tweet: "Don't be Pinkered into everything's-getting-better complacency."
- A new report by Oxfam argues that wealth inequality is causing poverty and misery around the world.
- In the last year, the world's billionaires saw their wealth increase by 12%, while the poorest 3.8 billion people on the planet lost 11% of their wealth.
- The report prompted Anand Giridharadas to tweet: "Don't be Pinkered into everything's-getting-better complacency." We explain what Steven Pinker's got to do with it.
Moans, groans, and gripes release stress hormones in the brain.
Could you give up complaining for a whole month? That's the crux of this interesting piece by Jessica Hullinger over at Fast Company. Hullinger explores the reasons why humans are so predisposed to griping and why, despite these predispositions, we should all try to complain less. As for no complaining for a month, that was the goal for people enrolled in the Complaint Restraint project.
Participants sought to go the entirety of February without so much as a moan, groan, or bellyache.
- Facebook and Google began as companies with supposedly noble purposes.
- Creating a more connected world and indexing the world's information: what could be better than that?
- But pressure to return value to shareholders came at the expense of their own users.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.